NCT01074632已完成1 期
A Phase 1, Open-Label Study to Determine the Effect of Calories and Fat Content on the Pharmacokinetics of Repeated Dose Lurasidone 120 mg in Subjects With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 26
- 试验地点
- 4
研究概览
简要总结
The objective of this study is to evaluate the effect of calorie and fat content on the pharmacokinetics of Lurasidone HCl in subjects with schizophrenia, schizoaffective disorder, or schizophreniform disorder.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female 18 to 65 years of age
- •BMI >= 19.5 and <= 37 kg/m2
- •No clinically relevant abnormal laboratory values
排除标准
- •History or presence of renal or hepatic insufficiency
- •Participated in a clinical trial in the past 30 days
- •Use of con meds that prolong the QT/QTc taken within 14 days prior to study drug administration
研究者
研究点 (4)
Loading locations...
相似试验
已完成
1 期
A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy SubjectsHealthy SubjectsNCT05843708Servier Bio-Innovation LLC64
已完成
1 期
The Effect of Food on the Pharmacokinetics (PK) of Emraclidine in Healthy Adult ParticipantsHealthyNCT05915546Cerevel Therapeutics, LLC16
已完成
1 期
A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168Anti-neutrophil Cytoplasmic Antibody-associated VasculitisNCT05988021Amgen16
已完成
1 期
A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy AdultsHealthy ParticipantsNCT05349864Pfizer12
已完成
1 期
A Study to Evaluate the Effect of Food on the Oral Bioavailability of Relacorilant in Healthy SubjectsHealthyNCT06094738Corcept Therapeutics30